Taking the Leap to Become a Global Medical Company
First written in FY2016. 27 of 31 entries say "Restated". Latest entry: 2026-08-06.
No other company in this theme has enough history to compare yet.
- FY2026-H1RestatedAnnual report
「Under the corporate philosophy of “contributing to the creation of comfortable and healthy human lives,” the Group develops businesses centered on health and medical care. Our mission is to contribute to people’s well-being through businesses including electrolyzed hydrogen water, electrolyzed-water dialysis and regenerative medicine.」
The Group has reaffirmed its corporate vision of contributing to well-being through electrolyzed hydrogen-rich water, electrolyzed water dialysis and regenerative medicine-related businesses, with health and healthcare at its core. - FY2025RestatedAnnual report
「Guided by the corporate philosophy of contributing to the creation of comfortable and healthy human lives, the Group develops businesses with health and healthcare as its main themes and aims to advance to a global medical company.」
The Group has reaffirmed its corporate vision of aiming to become a global medical company centered on health and healthcare. - FY2025-H1ReframedAnnual report
「Under the corporate philosophy of “contributing to the creation of comfortable and healthy human lives,” the Group develops businesses centered on health and medical care. Our mission is to contribute to people’s well-being through businesses including electrolyzed hydrogen water, electrolyzed-water dialysis and regenerative medicine.」
The Group has reaffirmed its corporate vision of contributing to well-being and a sustainable society centered on health and healthcare, while newly linking the PFAS removal performance of its water purifier cartridges to its contribution to creating a safer environment. - FY2024-Q3RestatedAnnual report
「Guided by the corporate philosophy of contributing to the creation of comfortable and healthy human lives, the Group develops businesses with health and healthcare as its main themes. Our mission is to contribute to people's well-being through businesses including electrolyzed hydrogen-rich water, electrolyzed water dialysis and regenerative medicine. Under the slogan “Society will always need our products,” we will contribute to creating a sustainable society and to the sustained enhancement of the Group's corporate value and shareholder value.」
The Group has reaffirmed its corporate vision of contributing to well-being and a sustainable society through electrolyzed hydrogen-rich water, electrolyzed water dialysis and regenerative medicine-related businesses, with health and healthcare at its core. - FY2024-Q2RestatedAnnual report
「Guided by the corporate philosophy of contributing to the creation of comfortable and healthy human lives, the Group develops businesses with health and healthcare as its main themes. Our mission is to contribute to people's well-being through businesses including electrolyzed hydrogen-rich water, electrolyzed water dialysis and regenerative medicine. Under the slogan “Society will always need our products,” we will contribute to creating a sustainable society and to the sustained enhancement of the Group's corporate value and shareholder value.」
The Group has reaffirmed its corporate vision of contributing to well-being and a sustainable society through electrolyzed hydrogen-rich water, electrolyzed water dialysis and regenerative medicine-related businesses, with health and healthcare at its core. - FY2024-Q1RestatedAnnual report
「Guided by the corporate philosophy of contributing to the creation of comfortable and healthy human lives, the Group develops businesses with health and healthcare as its main themes. Our mission is to contribute to people's well-being through businesses including electrolyzed hydrogen-rich water, electrolyzed water dialysis and regenerative medicine. Under the slogan “Society will always need our products,” we will contribute to creating a sustainable society and to the sustained enhancement of the Group's corporate value and shareholder value.」
The Group has reaffirmed its corporate vision of contributing to well-being and a sustainable society through electrolyzed hydrogen-rich water, electrolyzed water dialysis and regenerative medicine-related businesses, with health and healthcare at its core. - FY2023RestatedAnnual report
「Guided by the corporate philosophy of contributing to the creation of comfortable and healthy human lives, the Group develops businesses with health and healthcare as its main themes and aims to advance to a global medical company.」
The Group has reaffirmed its corporate vision of aiming to become a global medical company centered on health and healthcare. - FY2023-Q3ReframedAnnual report
「Guided by the corporate philosophy of contributing to the creation of comfortable and healthy human lives, the Group develops businesses with health and healthcare as its main themes and will contribute through its businesses to creating a well-being-oriented, sustainable society.」
In addition to the previous expression of advancing to a global medical company, the Group has broadened its corporate vision to include contributing to the creation of a well-being-oriented, sustainable society centered on health and healthcare. - FY2023-Q1RestatedAnnual report
「To achieve sustainable growth over the next 10 years, the Group will continue to take on the challenge of becoming a global medical company with the entrepreneurial spirit it has maintained since its founding.」
The Group has reaffirmed its policy of aiming to become a global medical company and indicated a time frame of sustainable growth over the next 10 years. - FY2022RestatedAnnual report
「We believe that, for the Group to become a medical company and achieve sustainable growth, it must further grow the water healthcare business, which accounts for approximately 88% of consolidated net sales, while establishing the healthcare-related business as a new business pillar.」
The Group has reaffirmed its policy of using the water healthcare business as its foundation while pursuing a medical company by establishing the healthcare-related business as a new business pillar. - FY2022-Q3RestatedAnnual report
「With the corporate philosophy of contributing to the creation of comfortable and healthy human lives, the Group aims to advance to a global medical company.」
The Group has reaffirmed its corporate philosophy and its corporate vision of advancing to a global medical company. - FY2021RestatedAnnual report
「The Group's businesses consist of water healthcare and healthcare-related businesses. Although water healthcare accounts for approximately 89% of consolidated net sales, we believe that establishing the healthcare-related business as a new business pillar is necessary for the Group to become a medical company and achieve sustainable growth.」
The Group has reaffirmed its policy of using the water healthcare business as its foundation while pursuing a medical company by establishing the healthcare-related business as a new business pillar. - FY2021-Q2RestatedAnnual report
「The Group is steadily moving toward becoming the global medical company it aims to be.」
The Group has reaffirmed its policy of aiming to become a global medical company. - FY2021-Q1RestatedAnnual report
「Although the healthcare-related businesses were affected by the COVID-19 pandemic, they have generally progressed smoothly, and the Group is steadily moving toward becoming the global medical company it aims to be.」
The Group has reaffirmed its recognition that, despite the impact of the COVID-19 pandemic, its healthcare-related businesses are progressing smoothly and it is moving toward becoming a global medical company. - FY2020AdvancedAnnual report
「The water healthcare business accounts for approximately 88% of consolidated net sales, but we believe that establishing the healthcare-related business as a new business pillar is necessary for the Group to become a medical company and achieve sustainable growth. The electrolyzed water dialysis business is now entering a stage where it can contribute to earnings, while the umbilical cord blood banking business is accelerating its growth. We will continue to work vigorously to further expand our healthcare-related businesses.」
The Group positioned the healthcare-related business as a new business pillar and went on to explain that electrolyzed water dialysis had entered the stage of contributing to earnings and that the umbilical cord blood banking business was accelerating its growth. - FY2020-Q3RestatedAnnual report
「The Group is steadily growing across all areas and steadily transitioning into the global medical company it aims to become.」
The Group has reaffirmed growth across all areas and the transition to a global medical company. - FY2020-Q2RestatedAnnual report
「The Group is steadily transitioning toward the global medical company it aims to become.」
The Group has reaffirmed its recognition that the transition to a global medical company is progressing smoothly. - FY2020-Q1RestatedAnnual report
「As described above, the Group is steadily advancing across all areas toward becoming a global medical company and is progressing smoothly as planned.」
The Group has reaffirmed its recognition that the transition to a global medical company is progressing smoothly as planned. - FY2019-Q3RestatedAnnual report
「As described above, while making upfront investments from a medium- to long-term perspective, the seeds of new businesses planted to date are beginning to take root, and the Group is steadily progressing across all areas toward becoming a global medical company.」
The Group has reaffirmed its recognition that, while continuing medium- to long-term upfront investment, its new businesses are progressing and it is moving toward becoming a global medical company. - FY2019-Q2RestatedAnnual report
「As described above, the Group is steadily advancing across all areas toward becoming a global medical company.」
The Group has reaffirmed its recognition that it is steadily progressing across all areas toward becoming a global medical company. - FY2019-Q1RestatedAnnual report
「As described above, the Group is steadily advancing across all areas toward becoming a global medical company.」
The Group has reaffirmed its recognition that it is steadily progressing across all areas toward becoming a global medical company. - FY2018-Q3RestatedAnnual report
「Across the Group, we are steadily advancing toward becoming a global medical company. To accelerate this progress, all employees will work to the fullest with an entrepreneurial spirit.」
The Group has reaffirmed its recognition that the transition to a global medical company is steadily progressing, as well as its commitment to accelerating the pace with an entrepreneurial spirit. - FY2018-Q2RestatedAnnual report
「To achieve sustainable growth in the future, the Group will actively expand overseas, particularly in Asia, and enter new business fields, including advanced medicine, while considering M&A, in addition to expanding its water ionizer sales business and its healthcare and agriculture businesses, thereby advancing to a global medical business group.」
The Group has reaffirmed its policy of pursuing a global medical business group through expansion from water ionizers into healthcare and agriculture, overseas expansion centered on Asia, and new business development with M&A in view. - FY2018-Q1RestatedAnnual report
「The Group is strengthening its structure to make advanced medicine the future core of the 日本トリム Group.」
The Group has reaffirmed its vision of making advanced medicine its core business and strengthening its structure to achieve this. - FY2017RestatedAnnual report
「Guided by its founding principles—(1) act in accordance with social justice, (2) contribute to creating comfortable and healthy human lives, (3) create world-first value based on scientific evidence, (4) create the world's one-and-only company through technologies originating in Japan, and (5) Trim is a community of shared destiny—the Group aims to advance from a home medical equipment manufacturer to a global medical company.」
The Group has reaffirmed its corporate vision of advancing from a home medical equipment manufacturer to a global medical company, with research collaboration with universities, hospitals and other institutions as the means of achieving it. - FY2017-Q2RestatedAnnual report
「To achieve sustainable growth in the future, the Group will focus not only on growing its water ionizer sales business, but also on expanding into new business areas such as agriculture and healthcare and in advanced medicine, thereby advancing from a home medical equipment manufacturer to a medical company.」
The Group has reaffirmed its policy of expanding from water ionizers into agriculture, healthcare and advanced medicine, with the aim of advancing to a medical company. - FY2017-Q1RestatedAnnual report
「To achieve sustainable growth in the future, the Group will accelerate the expansion of new business areas, including agriculture and healthcare, in addition to its water ionizer sales business, while also focusing on expanding in advanced medicine, thereby advancing from a home medical equipment manufacturer to a medical company.」
The Group has reaffirmed its policy of expanding from water ionizers into agriculture, healthcare and advanced medicine, with the aim of advancing to a medical company. - FY2016First statedAnnual report
「The Group aims to advance to a global medical company by expanding its business in functional water—electrolyzed hydrogen-rich water—and developing new businesses in the medical field.」
The Group presents a corporate vision combining expansion of its electrolyzed hydrogen-rich water business with the development of new businesses in the medical field.